- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/083 - Tripeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/083
Total number of patents in this class: 689
10-year publication summary
|
64
|
54
|
56
|
31
|
48
|
57
|
38
|
32
|
43
|
24
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4764 |
20 |
| ImmunoGen, Inc. | 375 |
15 |
| Biohaven Therapeutics Ltd. | 122 |
13 |
| Onyx Therapeutics, Inc. | 65 |
10 |
| Agency for Science, Technology and Research | 3753 |
8 |
| Kyoto University | 2926 |
8 |
| Arvinas Operations, Inc. | 247 |
8 |
| Merck Sharp & Dohme LLC | 3738 |
8 |
| Hoffmann-La Roche Inc. | 3825 |
7 |
| Northwestern University | 3564 |
7 |
| Supadelixir Inc. | 25 |
7 |
| Genentech, Inc. | 4119 |
6 |
| DSM IP Assets B.V. | 5390 |
6 |
| Purdue Research Foundation | 3941 |
6 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2313 |
6 |
| Gilead Pharmasset LLC | 40 |
6 |
| New York University | 1845 |
6 |
| Trustees of Tufts College | 985 |
6 |
| viDA Therapeutics Inc. | 15 |
6 |
| The Johns Hopkins University | 5922 |
5 |
| Other owners | 525 |